Download presentation
Presentation is loading. Please wait.
Published byEdmund Hetland Modified over 6 years ago
1
Impact of MenAfriVac in nine countries of the African meningitis belt, 2010–15: an analysis of surveillance data Caroline L Trotter, PhD, Clément Lingani, MSc, Katya Fernandez, MPH, Laura V Cooper, MPhil, André Bita, MD, Carol Tevi-Benissan, PhD, Olivier Ronveaux, MD, Marie-Pierre Préziosi, PhD, James M Stuart, FFPH The Lancet Infectious Diseases Volume 17, Issue 8, Pages (August 2017) DOI: /S (17) Copyright © 2017 World Health Organization. Published by Elsevier Ltd/Inc/BV. All rights reserved Terms and Conditions
2
Figure Total annual suspected and confirmed cases of bacterial meningitis across all nine countries in relation to MenAfriVac introduction (dotted line) Nm=N meningitidis. Non-A Nm=other meningococcal serogroups. Non-Nm=Pathogens other than N meningitides. The Lancet Infectious Diseases , DOI: ( /S (17) ) Copyright © 2017 World Health Organization. Published by Elsevier Ltd/Inc/BV. All rights reserved Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.